Suchergebnisse - "Dupilumab"

PubPharm (499)

1

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis : up to 5-year results from the daily practice BioDay Registry

enthalten in: Journal of the American Academy of Dermatology | 2024

von Zhang, J. | Boesjes, C. | Loman, L. | +21

2

Dupilumab treatment of trichothiodystrophy in a child

enthalten in: Pediatric dermatology | 2024

von Magnaterra, E. | Giovannini, M. | Filippeschi, C. | +7

3

Decoding real-world outcomes : Exploring clinical features associated with efficacy in patients treated with dupilumab

enthalten in: Journal of the American Academy of Dermatology | 2024

von Tong, Z. | Zhou, K. | Zou, Y. | +8

4

Dupilumab improves congenital ichthyosis

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2024

von Casetti, F. | Has, C.

5

Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2024

von Achten, R. | Thijs, J. | van der Wal, M. | +11

6

Comprehensive real-world comparisons between baricitinib and dupilumab treatments for moderate-to-severe atopic dermatitis

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Cho, Y. | Lee, M. | Chang, W. | +3

7

Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma : a retrospective cohort study

enthalten in: Journal of the American Academy of Dermatology | 2024

von Hasan, I. | Parsons, L. | Duran, S. | +1

8

Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation

enthalten in: Allergy | 2024

von Thormann, K. | Lüthi, A. | Deniau, F. | +12

9

Pharmaceutical industry-sponsored meals are associated with increased prescriptions and Medicare spending for dupilumab among dermatologists in the United States

enthalten in: Journal of evaluation in clinical practice | 2024

von Murayama, A.

10

Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab : A systematic review and meta-analysis

enthalten in: Journal of the American Academy of Dermatology | 2024

von Manzar, D. | Suntres, E. | Nair, N. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[50]